MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 97 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2013. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $99,000 | -71.1% | 79,719 | -28.2% | 0.00% | -75.0% |
| Q1 2017 | $342,000 | +41.3% | 110,976 | +87.2% | 0.00% | +100.0% |
| Q4 2016 | $242,000 | -39.3% | 59,286 | -5.6% | 0.00% | -50.0% |
| Q3 2016 | $399,000 | +324.5% | 62,819 | +260.4% | 0.00% | +300.0% |
| Q2 2016 | $94,000 | -89.6% | 17,432 | -83.6% | 0.00% | -92.3% |
| Q3 2015 | $905,000 | +438.7% | 106,340 | +681.7% | 0.01% | +550.0% |
| Q2 2015 | $168,000 | +66.3% | 13,603 | -1.6% | 0.00% | 0.0% |
| Q2 2014 | $101,000 | -91.6% | 13,821 | -94.2% | 0.00% | -90.0% |
| Q1 2014 | $1,202,000 | +869.4% | 238,467 | +927.7% | 0.02% | +900.0% |
| Q4 2013 | $124,000 | +12.7% | 23,205 | -19.9% | 0.00% | 0.0% |
| Q3 2013 | $110,000 | – | 28,973 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 775,571 | $2,389,000 | 0.93% |
| KEMPNER CAPITAL MANAGEMENT INC. | 148,985 | $459,000 | 0.31% |
| Yakira Capital Management, Inc. | 248,420 | $765,000 | 0.27% |
| GARRISON BRADFORD & ASSOCIATES INC | 87,700 | $270,000 | 0.24% |
| Cannell & Co. | 1,212,478 | $3,734,000 | 0.13% |
| LeJeune Puetz Investment Counsel LLC | 3,976 | $180,000 | 0.13% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 726,000 | $2,236,000 | 0.12% |
| Virtus ETF Advisers LLC | 198,735 | $612,000 | 0.11% |
| STONERIDGE INVESTMENT PARTNERS LLC | 199,227 | $614,000 | 0.08% |
| Birchview Capital, LP | 44,000 | $136,000 | 0.08% |